Famotidine Powder, For Suspension
Product Images NDC 51407-452

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 51407-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-452-50ol.jpg (51407 452 50ol)

51407-452-50ol.jpg (51407 452 50ol)
Each 5 mL of Famotidine oral suspension when reconstituted as directed contains 40 mg of Famotidine. The package insert should be consulted for dosage information. The dry powder and suspension should be stored between 15°C to 30°C. The remaining text is not-available.*
FDA Label Image

Structure (Famotidine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.